重复的芬太尼戒断加剧了阿片类药物戒断,并诱导了条状微质细胞的炎症状态
David J Bergkamp1,2, Kevin R Coffey1,3, Aliyah J Dawkins3
1Department of Psychiatry & Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, 98104, USA.
bioRxiv : the preprint server for biology
|November 24, 2025
概括
重复的阿片类药物戒断周期会使戒断症状恶化,并激活小鼠的微质细胞. 准微质先天免疫可能为阿片类药物成提供新的治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿片类药物戒断阻碍了戒断,并且可以在重复发作时恶化.
- 了解反复戒断的细胞机制对于开发有效的治疗方法至关重要.
研究的目的:
- 为了研究反复撤销芬太尼对小鼠状小质细胞的影响.
- 为了比较单个和多个戒断周期对微质基因表达和形态学的影响.
主要方法:
- 利用RiboTag技术,在接受芬太尼戒断的小鼠中,从条状小质细胞中分离出活性翻译RNA.
- 对比基因表达特征和微质形态在一次和五个周期的芬太尼暴露和戒断后.
- 使用RTqPCR确认了关键基因表达的变化.
主要成果:
- 与单一循环相比,五次芬太尼戒断周期显著改变了条纹性微质细胞.
- 重复的抽取减少了微质过程分支,表明更具反应性的状态.
- 多次戒断周期调节了参与天生的免疫的基因网络,包括"微细胞核心感官".
结论:
- 重复的阿片类药物戒断会在小鼠的条状小质细胞中诱导一种前炎性反应.
- 这些发现表明,准微质先天免疫反应可能是缓解严重阿片类药物戒断症状的治疗策略.
相关概念视频
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
892
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
892
Drug Dependence
1.6K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.6K
Opioid Receptors: Overview
3.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.9K


